Plain-English translation of NCT06647927 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Brugada syndrome is a rare genetic heart condition that can increase the risk of dangerous irregular heartbeats. This study is looking for genetic and molecular clues—like protein and metabolite patterns in blood—that could help doctors diagnose Brugada syndrome more accurately and without invasive testing. Researchers will analyze blood samples and genetic information from about 350 patients to discover these diagnostic markers.
Currently, diagnosing Brugada syndrome can be difficult and sometimes requires invasive procedures like heart testing. This trial aims to develop a simple blood test that could identify the condition more reliably, help doctors better assess risk, and deepen our understanding of how the disease works at the genetic level.
You likely qualify if…
You likely don't qualify if…
As a participant, you would donate a blood sample and share your genetic information for analysis. Researchers will use advanced genetic testing and machine learning to identify patterns that could serve as biomarkers for Brugada syndrome. The study doesn't require you to take any medications or undergo any invasive procedures—just a one-time or limited blood draw, depending on what the research team needs.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Italy
Azienda Ospedaliero Universitaria di Sassari, The National Research Council, Italy
Enrollment target
~350 participants
Started
December 2024
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Giuseppe Ciconte MD, PhD
IRCCS Policlinico S. Donato
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.